Update on Atrial Fibrillation: Part I

Clinical Cardiology - Tập 31 Số 2 - Trang 55-62 - 2008
Irina Savelieva1, A. John Camm1
1St George's University of London, London, U.K.

Tóm tắt

AbstractAtrial fibrillation (AF) is an epidemic, affecting 1% to 1.5% of the population in the developed world. Projected data from the population‐based studies suggest that the prevalence of AF will grow at least 3‐fold by 2050. The health and economic burden imposed by AF and AF‐related morbidity is enormous.Atrial fibrillation has a multiplicity of causes ranging from genetic to degenerative, but hypertension and heart failure are the commonest and epidemiologically most prevalent conditions associated with AF as both have been shown to create an arrhythmogenic substrate. Several theories emerged regarding the mechanism of AF, which can be combined into two groups: the single focus hypothesis and the multiple sources hypothesis. Several lines of evidence point to the relevance of both hypotheses to the mechanism of AF, probably with a different degree of involvement depending on the variety of AF (paroxysmal or persistent). Sustained AF alters electrophysiological and structural properties of the atrial myocardium such that the atria become more susceptible to the initiation and maintenance of the arrhythmia, a process known as atrial remodeling. Angiotensin II has been recognized as a key element in atrial remodeling in association with AF opening the possibility of exploitation of “upstream” therapies to prevent or delay atrial remodeling.The clinical significance of AF lies predominantly in a 5‐fold increased risk of stroke. The limitations of warfarin prompted the development of new antithrombotic drugs, which include anticoagulants, such as direct oral thrombin inhibitors (dabigatran) and factor Xa inhibitors (rivaroxaban, apixaban). Novel mechanical approaches for the prevention of cardioembolic stroke have recently been evaluated: percutaneous left atrial appendage occluders, minimally invasive surgical isolation of the left atrial appendage, and implantation of carotid filtering devices. Copyright © 2008 Wiley Periodicals, Inc.

Từ khóa


Tài liệu tham khảo

10.1046/j.1365-2796.2001.00908.x

10.1161/01.CIR.0000140263.20897.42

10.1093/eurheartj/ehi825

10.1001/jama.285.18.2370

10.1161/CIRCULATIONAHA.105.595140

10.1161/01.STR.22.8.983

10.1016/S0735-1097(00)00582-9

10.1161/01.CIR.0000083722.42033.0A

10.1016/j.pcad.2005.06.001

10.1007/s00439-005-0034-8

10.1136/hrt.2002.008748

10.1111/j.1524-4733.2006.00124.x

10.1023/A:1009823001707

10.1016/j.jacc.2003.08.027

10.1161/CIRCULATIONAHA.104.518837

10.1016/B978-0-443-06570-5.50021-6

10.1161/01.CIR.89.2.724

10.1161/CIRCULATIONAHA.104.517011

10.1161/01.CIR.103.5.769

10.1016/S0008-6363(02)00258-4

10.1016/S0008-6363(01)00521-1

10.1016/S0735-1097(03)00464-9

10.1161/hc4601.099402

10.1378/chest.119.1_suppl.194S

10.1001/archinte.1994.00420130036007

10.1161/01.STR.30.6.1223

10.1001/jama.285.22.2864

Fuster V, 2006, ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation‐executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients with Atrial Fibrillation), J Am Coll Cardiol, 48, 854

10.1111/j.1540-8175.2000.tb01152.x

10.1016/j.thromres.2005.08.007

10.1056/NEJM199608223350802

10.1111/j.1365-2141.2006.06134.x

10.1016/S0140-6736(06)68845-4

10.1016/j.jacc.2005.03.042

10.1016/j.jacc.2007.02.035

10.1016/j.ahj.2006.02.005

10.1016/j.ahj.2004.09.054

Thông tin
Thông tin xuất bản

Clinical Cardiology

Tập 31 Số 2

55-62

Thông tin tác giả